ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00920517
Recruitment Status : Completed
First Posted : June 15, 2009
Last Update Posted : January 3, 2013
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)